Compare GKOS & RIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GKOS | RIOT |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 8.1B |
| IPO Year | 2015 | 2002 |
| Metric | GKOS | RIOT |
|---|---|---|
| Price | $173.00 | $18.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 22 |
| Target Price | ★ $198.69 | $32.36 |
| AVG Volume (30 Days) | 723.3K | ★ 13.1M |
| Earning Date | 10-28-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $507,442,000.00 | ★ $647,435,000.00 |
| Revenue This Year | $36.18 | $4.49 |
| Revenue Next Year | $23.04 | $18.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 32.33 | ★ 71.89 |
| 52 Week Low | $73.16 | $11.50 |
| 52 Week High | $191.62 | $30.32 |
| Indicator | GKOS | RIOT |
|---|---|---|
| Relative Strength Index (RSI) | 56.54 | 36.54 |
| Support Level | $148.39 | $17.71 |
| Resistance Level | $184.68 | $19.07 |
| Average True Range (ATR) | 6.50 | 1.27 |
| MACD | 1.09 | -0.55 |
| Stochastic Oscillator | 89.32 | 5.76 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Riot Platforms Inc is a vertically integrated digital infrastructure company principally engaged in developing and optimizing its large-scale power assets. The Company's business centers on enhancing its electrical infrastructure and deploying it across two complementary platforms: (i) Bitcoin Mining and (ii) scalable data center solutions designed to support non-mining workloads. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.